C. Brightling (Leicester (Leicestershire), United Kingdom), J. Nieto-Fontarigo (Santiago De Compostela, Spain)
Identification of mechanism-specific biomarkers to guide development of the lung-selective inhaled pan-JAK inhibitor TD-8236
E. Gordon (South San Francisco, United States of America), E. Kaufman (South San Francisco, United States of America), R. Sana (South San Francisco, United States of America), A. Mcnamara (South San Francisco, United States of America), N. Pfeifer (South San Francisco, United States of America), E. Moran (South San Francisco, United States of America), G. Crater (South San Francisco, United States of America), M. Kleinschek (South San Francisco, United States of America), J. Woo (South San Francisco, United States of America), T. Southworth (Manchester, United Kingdom), T. Scott (Manchester, United Kingdom), D. Singh (Manchester, United Kingdom)
|   |
Oligomeric proanthocyanidin attenuated asthma severity by rebalanced epithelial phenotypes and airway microenvironment
Y. Gu (Nanjing, China), X. Zhong (Nanjing, China), H. Gu (Nanjing, China), Y. Ma (Nanjing, China), X. Zeng (Nanjing, China)
| |
Precision-cut lung slices as an in vitro model for testing of novel therapeutic agents
D. Belamaric (Zagreb, Croatia), M. Cedilak (Zagreb, Croatia), V. Radovanovic (Zagreb, Croatia), M. Banjanac (Zagreb, Croatia), L. Pribolsan (Zagreb, Croatia), V. Erakovic Haber (Zagreb, Croatia), M. Bosnar (Zagreb, Croatia)
| |
Thrombin induces stomatin-like protein 2 (STOML2) expression and IL-8/CXCL8 release by ROCK, JNK, and PEA3 pathways in human lung epithelial cells
B. Chen (Taipei, Taiwan), C. Lin (Taipei, Taiwan)
| |
A CADSET WP4 transcriptomic analysis of Asthma and COPD overlap
I. Adcock (London, United Kingdom), K. Sun (London, United Kingdom), N. Zounemat Kermani (London, United Kingdom), L. Lahousse (Ghent, Belgium), K. Chung (London, United Kingdom), R. Faner (Barcelona, Spain), G. Donaldson (London, United Kingdom), J. Wedzicha (London, United Kingdom), A. Agusti (Barcelona, Spain), M. Van Den Berge (Groningen, Netherlands)
| |
EP4 agonist increases myeloid derived suppressor cells activity and reduces airway inflammatory events in a murine model of asthma
C. Van Geffen (Tübingen, Germany), A. Dießler (Tübingen, Germany), S. Beer-Hammer (Tübingen, Germany), B. Nürnberg (Tübingen, Germany), S. Kolahian (Tübingen, Germany)
| |
A novel protective role of prostaglandin D2 in antigen-induced bronchoconstriction
J. Säfholm (Stockholm, Sweden), W. Abma (Stockholm, Sweden), J. Liu (Stockholm, Sweden), D. Balgoma (Stockholm, Sweden), J. Kolmert (Stockholm, Sweden), A. Fauland (Stockholm, Sweden), C. Wheelock (Stockholm, Sweden), M. Adner (Stockholm, Sweden), S. Dahlén (Stockholm, Sweden)
| |
Bronchial thermoplasty for the treatment of asthma patientswith COPD characteristics: an exploratory histopathological evaluation.
E. Papakonstantinou (Basel, Switzerland), T. Koletsa (Thessaloniki, Greece), M. Roth (Basel, Switzerland), M. Karakioulaki (Basel, Switzerland), S. Savic (Basel, Switzerland), L. Grize (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
| |
Degeneration of nerve fibers in chronic obstructive lung disease and usual interstitial pneumonia
J. Leopold (Graz, Austria), L. Brcic (Graz, Austria), S. Eidenhammer (Graz, Austria), W. Timens (Groningen, Netherlands), H. Popper (Graz, Austria)
| |
IND/GLY/MF: synergism in medium and small human hyperresponsive airways
P. Rogliani (Roma (RM), Italy), B. Ritondo (Roma (RM), Italy), I. Nikolaev (Basel, Swaziland), M. Cazzola (Roma (RM), Italy), M. Matera (Napoli, Italy), L. Calzetta (Roma (RM), Italy)
| |
The effect of inhaled corticosteroids on airway Na/K ATPase content in patients with asthma
M. Hvidtfeldt (Copenhagen, Denmark), A. Pulga (Copenhagen, Denmark), A. Sverrild (Copenhagen, Denmark), M. Hostrup (Copenhagen, Denmark), C. Sanden (Lund, Sweden), O. Nielsen (Aarhus, Denmark), D. Bornesund (Lund, Sweden), C. Clausson (Lund, Sweden), J. Erjefält (Lund, Sweden), C. Porsbjerg (Copenhagen, Denmark)
| |
GB001 potently inhibits PGD2 metabolite-induced DP2-mediated cell signaling and eosinophil activation
S. Murphy (San Diego, United States of America), T. Ismaili (San Diego, United States of America), K. Taylor Meadows (San Diego, United States of America), S. Sahdeo (San Diego, United States of America), H. Ortega (San Diego, United States of America), L. Carter (San Diego, United States of America), L. Salter-Cid (San Diego, United States of America)
| |
Differential effects of pharmacological leukotriene pathway modulators in a human lung tissue explant model
H. Olsson (Gothenburg, Sweden), S. Vollmer (Gothenburg, Sweden), L. Israelsson (Gothenburg, Sweden), J. Lindgren (Gothenburg, Sweden), Z. Jevnikar Rojnik (Gothenburg, Sweden)
| |
Pioglitazone inhibits obesity-related airway hyperreactivity
Z. Nie (Portland, United States of America), D. Jacoby (Portland, United States of America), A. Fryer (Portland, United States of America)
| |
Anti-inflammatory properties of synthetic and endogenous Rev-Erb-alpha agonists.
E. Sturm (Graz, Austria), D. Roula (Graz, Austria), P. Luschnig (Graz, Austria), I. Red (Graz, Austria), A. Heinemann (Graz, Austria)
| |
PI3K inhibitor add-on strategy improve glucocorticoid insensitivity in severe asthma
Z. Chen (Shanghai, China), J. Bi (Shanghai, China), Z. Min (Shanghai, China), C. Du (Shanghai, China)
| |